Increased density of prohibitin-immunoreactive oligodendrocytes in the dorsolateral prefrontal white matter of subjects with schizophrenia suggests extraneuronal roles for the protein in the disease

NeuroMolecular Medicine

Volumn 14, Issue 4, 2012, Pages 270-280

  Bernstein, Hans Gert ^a   Smalla, Karl Heinz ^b   Dürrschmidt, Diana ^a   Keilhoff, Gerburg ^a   Dobrowolny, Henrik ^a   Steiner, Johann ^a   Schmitt, Andrea ^c   Kreutz, Michael R ^b   Bogerts, Bernhard ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Immunohistochemistry; Morphometry; Oligodendrocytes; Prefrontal cortex; Prohibitin; Schizophrenia

Indexed keywords

HALOPERIDOL; PROHIBITIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANTERIOR CINGULATE; ARTICLE; BRAIN MITOCHONDRION; CELL COUNT; CELL DENSITY; CELL NUCLEUS; CELL POPULATION; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DORSOLATERAL PREFRONTAL WHITE MATTER; EMBRYO; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MORPHOMETRICS; MULTICENTER STUDY; NONHUMAN; OLIGODENDROGLIA; ORBITAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SCHIZOPHRENIA; WHITE MATTER;

ADULT; ANIMALS; ANTIPSYCHOTIC AGENTS; CELL COMPARTMENTATION; CELL COUNT; CELL CYCLE; CELL LINE, TRANSFORMED; CELL NUCLEUS; CEREBRAL CORTEX; FEMALE; GYRUS CINGULI; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; OLIGODENDROGLIA; PREFRONTAL CORTEX; PRIMARY CELL CULTURE; RATS; REPRESSOR PROTEINS; SCHIZOPHRENIA;

RATTUS;

EID: 84870478145     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-012-8185-y     Document Type: Article

References (59)

1. Behan, A. T., Byrne, C., Dunn, M. J., Cagney, G., & Cotter, D. R. (2009). Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression. Mol Psychiatry, 14, 601-613.
2. Benes, F. M. (2004). The role of apoptosis in neuronal pathology in schizophrenia and bipolar disorder. Current Opinion in Psychiatry, 17, 189-190.
3. Bernstein, H.-G., Baumann, B., Danos, P., Diekmann, S., Bogerts, B., Gundelfinger, E. D., et al. (1999). Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and VILIP-3) in human brain. Journal of Neurocytology, 28, 655-662.
4. Bernstein, H.-G., Smalla, K.-H., Mikhaylova, M., Sahin, J., Bogerts, B., Schmitt, A., et al. (2009a). Emerging roles of prohibitin in schizophrenia: Evidence from human postmortem studies and rat model of psychosis. European Archives of Psychiatry and Clinical Neuroscience, 259(Suppl1), S99.
5. Bernstein, H.-G., Stanarius, A., Baumann, B., Henning, H., Krell, D., Danos, P., et al. (1998). Nitric oxide synthase-containing neurons in the human hypothalamus: Reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience, 83, 867-875.
6. Bernstein, H.-G., Steiner, J., & Bogerts, B. (2009b). Glial cells in schizophrenia: Pathophysiological significance and possibleconsequences for therapy. Expert Reviews of Neurotherapeutics, 9, 1059-1071.
7. Bertram, I., Bernstein, H.-G., Lendeckel, U., Bukowska, A., Dobrowolny, H., Keilhoff, G., et al. (2007). Immunohistochemical evidence for impaired neuregulin-1 signaling in the prefrontal cortex in schizophrenia and in unipolar depression. Annals of the New York Acadamy of Sciences, 1096, 147-156.
8. Byne, W., Kidkardnee, S., Tatusov, S. A., Yiannoulos, G., Buchsbaum, M. S., & Haroutunian, V. (2006). Schizophrenia-associated reduction of neuronal and oligodendrocyte numbers in the anterior principal thalamic nucleus. Schizophrenia Research, 85, 245-253.
9. Clark, D., Dedova, I., & Matsumoto, I. (2011). Proteomics of the anterior cingulate cortex in schizophrenia. Advances in Neurobiology, 2, 381-398.
10. Danos, P., Baumann, B., Kramer, K., Bernstein, H.-G., Stauch, R., Krell, D., et al. (2003). Volumes of association thalamic nuclei in schizophrenia: a postmortem study. Schizophrenia Research, 60, 141-155.
11. Davis, K. L., Stewart, D. G., Friedman, J. I., Buchsbaum, M., Harvey, P. D., Hof, P. R., et al. (2003). White matter changes in schizophrenia: evidence for myelin-related dysfunction. Archives of General Psychiatry, 60, 443-456.
12. Dean, B., Crook, J. M., Pavey, G., Opeskin, K., & Copolov, D. L. (2000). Muscarinic 1 and 2 receptor mRNA in the human caudate-putamen: no change in m1mRNA in schizophrenia. Molecular Psychiatry, 5, 203-207.
13. DeLisi, L. E., & Fleischhaker, W. (2007). Schizophrenia research in the era of the genome. Current Opinion in Psychiatry, 20, 109-110.
14. Durrschmidt, D., Smalla, K.-H., Kreutz, M. R., Dobrowolny, H., Steiner, J., Keilhoff, G., et al. (2010). Increased oligodendroglial expression of the cell proliferation-controlling protein prohibitin in schizophrenia. A hint for cell cycle abnormalities Acta Clinica Croatica, 49(Suppl 2), 39-41.
15. Escamilla, M., Hare, E., Dassori, A. M., Peralta, J. M., Ontiveros, A., Nicolini, H., et al. (2009). A schizophrenia gene locus on chromosome 17q21 in a new set of families of Mexican and central american ancestry: evidence from the NIMH Genetics of schizophrenia in latino populations study. American Journal of Psychiatry, 166, 442-449.
16. Farkas, N., Lendeckel, U., Dobrowolny, H., Funke, S., Steiner, J., Keilhoff, G., et al. (2010). Reduced density of ADAM 12-immunoreactive oligodendrocytes in the anterior cingulate white matter of patients with schizophrenia. World Journal of Biological Psychiatry, 11, 556-566.
17. Fornito, Y., Yucel, M., Wood, S. J., & Pantelis, C. (2009). Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology. Schizophrenia Bulletin, 35, 973-993.
18. Glantz, L. A., Gilmore, J. H., Overstreet, D. H., Salimi, K., Lieberman, J. A., & Jarskog, L. F. (2010). Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depression. Schizophrenia Research, 118, 292-299.
19. Govekar, R. B., D'Cruz, A. K., Alok Pathak, K., Agarwal, J., Dinshaw, K. A., Chinoy, R. F., et al. (2009). Proteomic profiling of cancer of the gingivo-buccal complex: Identification of new differentially expressed markers. Proteomics Clinical and Applied, 3, 1451-1462.
20. Hakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., et al. (2001). Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proceedings of the National Acadademy of Sciences of the USA, 98, 4746-4751.
21. Hamshere, M. L., Holmans, P. A., McCarthy, G. M., Jones, L. A., Murphy, K. C., Sanders, R. D., et al. (2011). Phenotype evaluation and genomewide linkage study of clinical variables in schizophrenia. American Journal of Medical Genetics Section B Neuropsychiatric Genetics, 156, 929-940.
22. Hof, P. R., Haroutunian, V., Copland, C., Davis, K. L., & Buxbaum, J. D. (2002). Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochemical Research, 27, 1193-1200.
23. Hof, P. R., Haroutunian, V., Friedrich, V. L., Jr, Byne, W., Buitron, C., Perl, D. P., et al. (2003). Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biological Psychiatry, 53, 1075-1085.
24. Hoistad, M., Segal, D., Takahashi, N., Sakurai, T., Buxbaum, J. D., & Hof, P. R. (2009). Linking white and grey matter in schizophrenia: oligodendrcyte and neuron pathology in the prefrontal cortex. Frontiers in Neuroanatomy, 3, 9.
25. Hsu, S. M., & Soban, E. (1982). Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry. Journal of Histochemistry and Cytochemistry, 30, 1079-1082.
26. Katsel, P., Byne, W., Roussos, P., Tan, W., Siever, L., & Haroutunian, V. (2011). Astrocyte and glutamate markers in the superficial, deep, and white matter layers of the anterior cingulate gyrus in schizophrenia. Neuropsychopharmacology, 36, 1171-1177.
27. Katsel, P., Davis, K. L., Li, C., Tan, W., Greenstein, E., Kleiner Hoffman, L. B., et al. (2008). Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes. Neuropsychopharmacology, 33, 2993-3009.
28. Kirkpatrick, B., Messias, N. C., Conley, R. R., & Roberts, R. C. (2003). Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficient and nondeficient schizophrenia. Journal of Nervous and Mental Disease, 191, 563-567.
29. Kostović, I., Judas, M., & Sedmak, G. (2011). Developmental history of the subplate zone, subplate neurons and interstitial white matter neurons: relevance for schizophrenia. International Journal of Developmental Neuroscience, 29, 193-205.
30. Kuwamura, M., Inumaki, K., Tanaka, M., Shirai, M., Izawa, T., Yamate, J., et al. (2011). Oligodendroglial pathology in the development of myelin breakdown in the dmy mutant rat. Brain Research, 1389, 161-168.
31. Mai, J. K., Assheuer, J., & Paxinos, G. (2003). Atlas of the Human Brain. San Diego: Academic.
32. Martins-De-Souza, D., Dias-Neto, E., Schmitt, A., Falkai, P., Gormanns, P., Maccarrone, G., et al. (2010). Proteome analysis of schizophrenia brain tissue. World Journal of Biological Psychiatry, 11, 110-120.
33. Martins-de-Souza, D., Gattaz, W. F., Schmitt, A., Maccarrone, G., Hunyadi-Gulyás, E., Eberlin, M. N., et al. (2009a). Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. Journal of Psychiatric Research, 43, 978-986.
34. Martins-de-Souza, D., Gattaz, W. F., Schmitt, A., Rewerts, C., Maccarrone, G., Dias-Neto, E., et al. (2009b). Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 259, 151-163.
35. Merkwirth, C., Dargazanli, S., Tatsuta, T., Geimer, S., Lower, B., Wunderlich, F. T., et al. (2008). Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes & Development, 22, 476-488.
36. Mishra, S., Ande, S. R., & Nyomba, B. L. (2010). The role of prohibitin in cell signaling. FEBS Journal, 277, 3937-3946.
37. Mitkus, S. N., Hyde, T. M., Vakkalanka, R., Kolachana, B., Weinberger, D. R., Kleinman, J. E., et al. (2008). Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia. Schizophrenia Research, 98, 129-138.
38. Mitterauer, B. J., & Kofler-Westergren, B. (2011). Possible effects of synaptic imbalances on oligodendrocyte-axonic interactions in schizophrenia: a hypothetical model. Frontiers in Psychiatry, 2, 15. doi:10.3389/fpsyt.2011. 00015.
39. Novak, G., & Tallerico, T. (2006). Nogo A, B and C expression in schizophrenia, depression and bipolar frontal cortex, and correlation of Nogo expression with CAA/TATC polymorphism in 30 -UTR. Brain Research, 1120, 161-171.
40. Papanastasiou, E., Gaughran, F., & Smith, S. (2011). Schizophrenia as segmental progeria. Journal of the Royal Society of Medicine, 104, 475-484.
41. Prabakaran, S., Swatton, J. E., Ryan, M. M., Huffaker, S. J., Huang, J. T.-J., Griffin, J. L., et al. (2004). Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Molecular Psychiatry, 9, 684-697.
42. Rezin, G. T., Amboni, G., Zugno, A. I., Quevedo, J., & Streck, E. L. (2009). Mitochondrial dysfunction and psychiatric disorders. Neurochemical Research, 34, 1021-1029.
43. Schmitt, A., Hasan, A., Gruber, O., & Falkai, P. (2011). Schizophrenia as a disorder of disconnectivity. European Archives of Psychiatry and Clinical Neuroscience, 261(Suppl 2), 150-154.
44. Schmitt, A., Otto, S., Jatzko, A., Ruf, M., Demirakca, T., Tost, H., et al. (2009a). Parieto-prefrontal dysfunction during visuoauditory information processing in elderly, chronic schizophrenic patients and medication effects. Revista Psiquiatrica Clinica., 36, 89-96.
45. Schmitt, A., Steyskal, C., Bernstein, H.-G., Schneider-Axmann, T., Parlapani, E., Schaeffer, E. L., et al. (2009b). Stereologic investigation of the posterior part of the hippocampus in schizophrenia. Acta Neuropathologica, 117, 395-407.
46. Schubert, K. O., Focking, M., Prehn, J. H. M. & Cotter, D. R. (2011). Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder Molecular Psychiatry advance online publication 11 Oct 2011; doi:10.1038/mp.2011.123.
47. Segal, D., Koschnick, J. R., Slegers, L. H., & Hof, P. R. (2007). Oligodendrocyte pathophysiology: a new view of schizophrenia. International Journal of Neuropsychopharmacology, 10, 503-511.
48. Selemon, L. D., & Rajkowska, G. (2003) Cellular pathology in the dorsolateral prefrontal cortex distinguishes schizophrenia from bipolar disorder. Curr Mol Med, 60, 69-77.
49. Smalla, K. H., Mikhaylova, M., Sahin, J., Bernstein, H.-G., Bogerts, B., Schmitt, A., et al. (2008). A comparison of the synaptic proteome in human chronic schizophrenia and rat ketamine psychosis suggest that prohibitin is involved in the synaptic pathology of schizophrenia. Molecular Psychiatry., 13, 878-896.
50. Sripathi, S. R., He, W., Atkinson, C. L., Smith, J. J., Liu, Z., Elledge, B. M., et al. (2011). Mitochondrial-nuclear communication by prohibitin shuttling under oxidative stress. Biochemistry, 50, 8342-8351.
51. Steiner, J., Bernstein, H.-G., Bogerts, B., Gos, T., Richter-Landsberg, C., Wunderlich, M. T., et al. (2008). S100B is expressed in, and released from, OLN-93 oligodendrocytes: Influence of serum and glucose deprivation. Neuroscience, 154, 496-503.
52. Steiner, J., Mawrin, C., Ziegeler, A., Bielau, H., Ullrich, O., Bernstein, H.-G., et al. (2006). Distribution of HLA-DR positive microglia in schizophrenia reflects impaired cerebral lateralization. Acta Neuropathologica, 112, 305-316.
53. Theiss, A. L., & Sitaraman, S. V. (2011). The role and therapeutic potential of prohibitin in disease. Biochimica et Biophysica Acta, 1813, 1137-1143.
54. Uranova, N. A., Orlovskaya, D. D., Vikhreva, O. V., Zimina, I. S., & Rakhmanova, V. I. (2001). Morphometric study of ultrastructural changes in oligodendroglial cells in the postmortem brain in endogenous psychoses. Vestnik Rossiskoy Akadamii Medicinskych Nauk, 7, 42-48.
55. Uranova, N. A., Vostrikov, V. M., Orlovskaya, D. D., & Rachmanova, V. I. (2004). Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophrenia Research, 67, 269-275.
56. Walterfang, M., Velakoulis, D., Whitford, T. J., & Pantelis, C. (2011). Understanding aberrant white matter development in schizophrenia: an avenue for therapy Expert Reviews in Neurotherapeutics, 11, 971-987.
57. Yang, Y., Fung, S. J., Rothwell, A., Tianmei, S., & Weickert, C. S. (2011). Increased interstitial white matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia. Biological Psychiatry, 69, 63-70.
58. Zech, M., Roberts, G. W., Bogerts, B., Crow, T. J., & Polak, J. M. (1986). Neuropeptides in the amygdala of controls, schizophrenics and patients suffering from Huntington's Chorea: an immunohistochemical study. Acta Neuropathol, 71, 259-266.
59. Zhou, P., Qian, L., D'Aurelio, M., Cho, S., Wang, G., Manfredi, G., et al. (2012). Prohibitin reduces mitochondrial free radical production and protects brain cells from different injury modalities. Journal of Neuroscience, 35, 583-592.